# Psychiatric Research * **Definition:** Research focused on understanding and treating mental illnesses. * **Taxonomy:** Specialties / Psychiatric Research ## News * Selected news on the topic of **Psychiatric Research**, for healthcare technology leaders * 1.5K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/23/2025 | [**Dr. Elsey's Expands Its Vision Beyond Litter--Supporting the Emotional Bond Between Cats and ...**](https://www.prnewswire.com/news-releases/dr-elseys-expands-its-vision-beyond-littersupporting-the-emotional-bond-between-cats-and-their-people-302463647.html) | [[PR Newswire]] | | 4/25/2025 | [**Nexalin Technology receives IRB approval in Brazil, begins trial - Markets Insider**](https://markets.businessinsider.com/news/stocks/nexalin-technology-receives-irb-approval-in-brazil-begins-trial-1034621755) | [[Business Insider Markets]] | | 4/14/2025 | [**Overcoming Challenges in Psychiatry Clinical Research: Innovations in Patient Retention and Collaborative Care, Upcoming Webinar Hosted by Xtalks**](https://www.prweb.com/releases/overcoming-challenges-in-psychiatry-clinical-research-innovations-in-patient-retention-and-collaborative-care-upcoming-webinar-hosted-by-xtalks-302427715.html) | [[PRWeb]] | | 2/3/2025 | [**Representativeness in Pragmatic Clinical Trials**](https://jamanetwork.com/journals/jama/fullarticle/2826609) | [[JAMA Network]] | | 12/16/2024 | [**Rachel Rhodes, D.O. Joins TeleMed2U as National Director of Behavioral Health Services**](https://www.morningstar.com/news/business-wire/20241216138656/rachel-rhodes-do-joins-telemed2u-as-national-director-of-behavioral-health-services) | [[Morningstar]] | | 12/16/2024 | [**Rachel Rhodes, D.O. Joins TeleMed2U as National Director of Behavioral Health Services**](https://finance.yahoo.com/news/rachel-rhodes-d-o-joins-150000870.html) | [[Yahoo Finance]] | | 12/3/2024 | [**Sutter Partners With Concert Health on Collaborative Care Program**](https://www.hcinnovationgroup.com/population-health-management/behavioral-health/news/55247130/sutter-partners-with-concert-health-on-collaborative-care-program) | [[Healthcare Innovation]] | | 11/29/2024 | [**Click Therapeutics Launches Software-Enhanced Drug Therapies**](https://thehealthcaretechnologyreport.com/click-therapeutics-launches-software-enhanced-drug-therapies/) | [[Healthcare Technology Report]] | | 11/21/2024 | [**Array Behavioral Care and KeyCare Partner to Improve Mental Health Integration -**](https://hitconsultant.net/2024/11/21/array-behavioral-care-and-keycare-partner-to-improve-mental-health-integration/) | [[HIT Consultant]] | | 11/20/2024 | [**New collaboration aims to improve mental health services for primary care patients**](https://www.news-medical.net/news/20241120/New-collaboration-aims-to-improve-mental-health-services-for-primary-care-patients.aspx) | [[News Medical Net]] | | 11/17/2024 | [**Then vs. Now: Changes in Biomedical Research Over 50 Years**](https://www.psychologytoday.com/us/blog/mental-health-care-today/202411/then-vs-now-changes-in-biomedical-research-over-50-years) | [[Psychology Today]] | | 11/16/2024 | [**Then vs. Now: Changes in Biomedical Research Over 50 Years**](https://www.psychologytoday.com/za/blog/mental-health-care-today/202411/then-vs-now-changes-in-biomedical-research-over-50-years) | [[Psychology Today]] | | 11/14/2024 | [**CEO of Otsuka North America: Are We Getting better access with AI?**](https://medcitynews.com/2024/11/ceo-of-otsuka-north-america-are-we-getting-better-access-with-ai/) | [[MedCity News]] | | 10/23/2024 | [**'Inflexible thinking style' behind why some people won't accept vaccines, says new research**](https://medicalxpress.com/news/2024-10-inflexible-style-people-wont-vaccines.html) | [[MedicalXpress]] | | 10/16/2024 | [**Brain Research Foundation Awards 2024 Outstanding Achievement Prizes to Six Leading Psychiatric Researchers**](https://markets.businessinsider.com/news/stocks/brain-behavior-research-foundation-awards-2024-outstanding-achievement-prizes-to-six-leading-psychiatric-researchers-1033852103) | [[Business Insider Markets]] | | 10/16/2024 | [**Brain Research Foundation Awards 2024 Outstanding Achievement Prizes to Six Leading Psychiatric Researchers**](https://www.morningstar.com/news/globe-newswire/9257251/brain-behavior-research-foundation-awards-2024-outstanding-achievement-prizes-to-six-leading-psychiatric-researchers) | [[Morningstar]] | | 9/23/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823929) | [[JAMA Network]] | | 9/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823031) | [[JAMA Network]] | | 8/26/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822727) | [[JAMA Network]] | | 8/19/2024 | [**5 Hospital Stocks Poised to Benefit From Strong Industry Growth - Yahoo Finance**](https://finance.yahoo.com/news/5-hospital-stocks-poised-benefit-150200616.html) | [[Yahoo Finance]] | | 8/12/2024 | [**Audio Highlights**](https://jamanetwork.com/journals/jama/fullarticle/2822137) | [[JAMA Network]] | | 8/5/2024 | [**CMS Finalizes Medicare Payment Rule for Hospitals, Focuses on Equity, Safety, and Innovation**](https://hitconsultant.net/2024/08/05/cms-finalizes-medicare-payment-rule-for-hospitals/) | [[HIT Consultant]] | | 7/14/2024 | [**Thriveworks, Ophelia Team Up for Mental Health, OUD Support**](https://medcitynews.com/2024/07/thriveworks-ophelia-team-up-for-mental-health-oud-support/) | [[MedCity News]] | | 6/17/2024 | [**Precision Medicine**](https://www.healthcareitnews.com/category/resource-topic/precision-medicine) | [[Healthcare IT News]] | | 5/31/2024 | [**Talkspace, Labcorps Ovia Health Launch Digital Womens Health Coalition**](https://medcitynews.com/2024/05/talkspace-labcorps-ovia-health-launch-digital-womens-health-coalition/) | [[MedCity News]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Stanley Center for Psychiatric Research**: A research center focused on understanding psychiatric disorders through innovative methods, including stem cell research. - **University of Barcelona**: A leading institution conducting research on psychiatric disorders, focusing on facial shape differences linked to schizophrenia and bipolar disorder. - **Adams Clinical**: A clinical research organization expanding its capabilities in psychiatric and neurologic illness trials through partnerships. - **Vanderbilt University Medical Center**: Conducted research linking sexual trauma and genetic predisposition to increased risk of mental illnesses. - **Brain & Behavior Research Foundation**: An organization that funds psychiatric research and recognizes outstanding contributions in the field. - **Brain & Behavior Research Foundation (BBRF)**: A leading organization that funds psychiatric research and supports early career scientists through grants. - **Teva Pharmaceuticals**: A pharmaceutical company conducting significant research on treatment outcomes for mental health conditions. - **Dr. Edward Scolnick**: A scientist dedicated to researching schizophrenia and bipolar disorder, focusing on improving treatment options. - **Weill Cornell Medicine**: A research institution exploring the use of reinforcement learning to improve treatment strategies for psychiatric conditions. - **Dr. Madhukar Trivedi**: Researcher exploring EEG as a cost-effective alternative to fMRI for assessing suicidal ideation. - **Dr. Consuelo Walss-Bass**: A leading researcher in psychiatric genetics, known for her work on the genetic predisposition and environmental factors in severe mental health disorders. - **Dr. Brajesh Agrawal**: Chief Medical Officer of Adaptive Research, emphasizing the importance of integrating clinical trials into community mental health practices. - **Professor Barbara Franke**: A molecular psychiatrist at Radboud University, recognized for her research on the genetic basis of neurodevelopmental conditions, particularly ADHD. - **Prodigy Psychiatric Group**: A provider of comprehensive mental health services, including individual therapy and medication management, known for exploring innovative solutions for patient care. - **Dr. Beeta Verma**: Leader of Prodigy Psychiatric Group, focusing on enhancing patient care through innovative research collaborations. - **Headlamp Health**: Company specializing in precision psychiatry, leveraging AI to improve mental health care delivery. - **HMNC Brain Health**: A clinical-stage precision psychiatry biopharma company developing personalized therapies for major depressive disorder. - **HiBoop**: A technology platform that consolidates mental health research into a comprehensive assessment tool to improve diagnosis and treatment for mental health conditions. - **Huntsman Mental Health Foundation**: An organization dedicated to advancing mental health research and care, currently constructing a facility for brain research. - **WashU Medicine**: A medical institution utilizing philanthropic support to enhance its neurosurgery department and advance psychiatric research. ### Partnerships and Collaborations - **Adaptive Research and Prodigy Psychiatric Group**: A partnership aimed at enhancing access to psychiatric clinical trials for patients in community settings, improving diagnosis and treatment of psychiatric conditions. - **Stanley Center for Psychiatric Research**: Collaborates with various researchers to analyze cell morphology and responses to pharmacological treatments. - **Adams Clinical and InSite Clinical Research**: Working together to expand capabilities in conducting clinical trials for psychiatric and neurologic illnesses. - **Northwestern Medicine, West Health, and Meadows Mental Health Policy Institute**: Launched an initiative to improve access to evidence-based mental health services in primary care settings. - **McGill University**: Partnering with French institutions to explore neurological mechanisms behind anorexia nervosa. - **Holmusk**: Released NeuroBlu Analytics v4.6, expanding its dataset through partnerships to enhance research capabilities in psychiatric treatment. - **Talkiatry and Biogen**: A partnership aimed at improving access to mental health support for new mothers experiencing postpartum depression. - **Dassault Systèmes and FondaMental Foundation**: Collaboration to create a Health Data Warehouse for secure processing and analysis of complex clinical data related to psychiatric disorders. - **University of North Carolina - Chapel Hill**: Developing non-invasive brain stimulation technology for depression treatment. - **Reviva Pharmaceuticals**: Hosted an event to discuss the results of the RECOVER trial, showcasing collaboration with key opinion leaders in psychiatry. - **University of Arkansas for Medical Sciences**: Collaborating on mental health treatment programs for women affected by opioid abuse. - **HiBoop and The Healing Institute**: Collaborating to enhance mental health assessments and improve diagnosis times for patients. - **Cystic Fibrosis Foundation and University at Buffalo**: Collaboration to enhance mental health screening and treatment for children with cystic fibrosis. - **Medidata and Cogstate**: Partnering to improve clinical trials and outcomes measurement for central nervous system diseases. - **Amae Health and Cedars-Sinai**: Partnership focuses on integrated care for severe mental illnesses, enhancing patient outcomes through data-driven approaches. - **United BioSource LLC and Osmind Inc.**: Collaborated to integrate REMS into EHR systems, improving data quality and compliance in mental health care. - **Thriveworks and Ophelia**: A partnership aimed at facilitating referrals for patients with opioid use disorder and extensive mental health care needs. - **Array Behavioral Care and KeyCare**: Collaborated to enhance mental health treatment through a unified Epic-based platform, improving care coordination. - **Sutter Health and Concert Health**: Partnered to co-manage treatment for patients with behavioral health disorders, improving access to care. - **NeuroKaire and Pharmaceutical Companies**: NeuroKaire aims to enhance drug development processes by integrating precision medicine throughout the developmental pipeline. ### Innovations, Trends, and Initiatives - **Webinar on Psychiatry Trials**: A free webinar focusing on best practices for conducting psychiatry clinical trials, emphasizing patient-centric approaches. - **Young Investigator Grants**: BBRF awarded $10.4 million to 150 early career scientists focusing on various psychiatric illnesses. - **AI in Mental Health Research**: Integration of artificial intelligence to enhance diagnostic accuracy and treatment personalization in psychiatric care. - **Telepsychiatry**: Array Behavioral Care's introduction of telepsychiatry has transformed access to mental health services, including involuntary commitments. - **Reinforcement Learning in Psychiatry**: Research from Weill Cornell Medicine highlights the potential of reinforcement learning to assist in developing sequential treatment strategies for improved patient outcomes. - **AI in Psychiatry**: Artificial intelligence is being leveraged to enhance understanding of mental illness and create personalized treatment plans. - **Machine Learning in Postpartum Mental Health**: Recent studies utilizing machine learning to predict risks for postpartum depression and psychosis, enhancing early detection and treatment. - **EEG for Suicidal Ideation**: Research indicates EEG could serve as an accessible method for testing patients for suicidal ideation. - **Digital Psychiatry**: Legion Health raised $6.3 million to pivot towards operating a digital psychiatry practice that leverages AI for improved efficiency. - **Pharmacogenetic Testing**: NeuroKaire's comprehensive pharmacogenetic assay analyzes genetic variants to optimize treatment plans for mental health disorders. - **Pragmatic Clinical Trials (PCTs)**: A trend towards integrating clinical research into routine patient care to generate practical evidence more efficiently. - **Wearable Technology**: Mass General Brigham researchers are investigating ingestible sensors to improve medication adherence in psychiatric care. - **TIDES 2.0 Study**: A study evaluating mental health issues in children with cystic fibrosis, aiming to develop effective screening methods. - **Digital Endpoints in Clinical Trials**: Clario's webinar focuses on using digital endpoints to improve data accuracy in psychiatric drug development. - **Brain Stimulation Technology**: A new non-invasive treatment for depression shows promise in clinical trials, with high rates of symptom relief. - **Natural Language Processing and AI**: Future research aims to utilize AI to identify social determinants of health in electronic health records for genomic studies. - **Collaborative Behavioral Health Program**: Northwestern Medicine's initiative integrating mental health care into primary care to optimize treatment for patients. - **AI in Mental Health**: Headlamp Health aims to leverage AI for actionable data and patient-specific solutions, addressing the growing demand for mental health resources. - **New Schizophrenia Medication**: FDA approval of a new medication represents a significant advancement in treatment options for schizophrenia. - **Comp Cog AI**: A new AI method developed to predict anxiety levels using minimal computational resources and a limited set of variables. ### Challenges and Concerns - **Regulatory Changes in Research**: The shift from investigator-initiated studies to for-profit research organizations has raised concerns about the integrity and focus of psychiatric research. - **Neuroimaging Limitations**: Current neuroimaging technologies are not reliable for diagnosing psychiatric conditions, emphasizing the need for clinical methods. - **Geographic Disparities in Pediatric Psychiatric Care**: Research shows a lack of inpatient psychiatric beds for children, particularly in rural areas, raising concerns about equitable access to care. - **Access to Psychiatric Care**: A study indicates significant access issues for Medicaid enrollees needing psychiatric care, with only 18% of psychiatrists reachable and available for appointments. - **Long-term Drug Development**: Concerns regarding the implications of new pricing regulations on drug development, particularly in psychiatry and oncology. - **Suicide Prevention**: In-hospital suicides remain a critical public health issue, particularly in regions with stigma surrounding mental health. - **Misinformation in Mental Health**: The COVID-19 pandemic highlighted the spread of misinformation affecting mental health, necessitating awareness and research on its impact. - **Access to Care**: Access to psychiatrists is hindered by insurance market failures and low payment rates, complicating the practice for many psychiatrists. - **Neuropsychiatric Safety of Medications**: Concerns regarding the neuropsychiatric safety of drugs like semaglutide necessitate further research. - **Polypharmacy Risks**: Concerns regarding the increasing trend of polypharmacy in psychiatric care, highlighting the compounded risks associated with multiple medications. - **Medicaid Funding Issues**: Texas psychiatric hospitals face financial strain due to stagnant Medicaid rates, impacting the availability of mental health services. - **Provider Burnout**: Mental health providers often experience burnout due to current options and face challenges in outpatient psychiatry. - **Antipsychotic Use Without Oversight**: Concerns about patients on long-term antipsychotics lacking regular monitoring, leading to potential health risks. - **Clinical Research Sustainability**: Experts criticize the current clinical research enterprise for being expensive and unsustainable, with many trials failing to produce generalizable evidence. - **Access to Mental Health Care**: Despite increased awareness, over 30 million people in the U.S. lack access to quality mental health care, emphasizing the need for expanded services. - **Need for Effective Treatments**: There is a pressing need for more effective pharmacological options for alcohol use disorder due to high relapse rates. - **Sleep and Suicidal Ideation**: Disturbed sleep significantly contributes to heightened suicidal ideation, yet it is often overlooked in clinical settings. - **Access to Treatment**: Only one-third of outpatient mental health facilities offer medications for opioid use disorder, highlighting barriers to care. - **Rising Research Costs**: The pharmaceutical industry faces challenges due to high research and development costs, impacting drug development timelines and success rates.